Vanberra Signal

coding.bio

Curated by Signal

AI-assisted platform for cell therapy development

Overview

AI-assisted platform for cell therapy development. The platform utilizes machine learning technology to screen and identify lead candidates (Chimeric Antigen Receptors) for cell therapy. It uses automation & computation technology for the identification of Chimeric Antigen Receptor (CRAs) for therapeutics.

Key facts

Founded
2021

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of non-invasive wearable sensors for tracking biomarkers

    Health TechnologyCambridge, United Kingdom
  • Provider of an AI led decision and planning support solutions for healthcare

    Health TechnologyWarrington, United Kingdom
  • Online platform offering video consultation and expert second opinions

    Health TechnologyLiverpool, United Kingdom

About coding.bio

What does coding.bio do?

AI-assisted platform for cell therapy development.

Where is coding.bio headquartered?

coding.bio is headquartered in Oxford, United Kingdom.

When was coding.bio founded?

coding.bio was founded in 2021.

Which sector is coding.bio in?

coding.bio operates in Health Technology.

Who are coding.bio's competitors?

Companies similar to coding.bio include Vizer Life, Horizons New, and Choice Health.